A top executive of DISH Network argued on Monday, March 26, that AT&T’s planned purchase of Time Warner Inc would give AT&T too much power to block competitors’ access to crucial content.
The US government is seeking to stop the US$85 billion deal, arguing that it would hurt consumers. Monday’s testimony was the second day of the trial that is due to last six to eight weeks.
Testifying for the government, Warren Schlichting, who negotiates to buy programming for DISH’s satellite and its Sling internet business, said that his company needed to have the rights to broadcast some Time Warner content, especially news like CNN and sports, like college basketball’s March Madness, in order to attract and keep subscribers.
“These negotiations are tough,” said Schlichting. “That’s so even without the merger. Turner has a good negotiating team. With the merger, all the incentives change, and we have one of our most important licensors teaming up with our biggest adversary. I just don’t know what incentive Time Warner would have to get a deal done.”
By adversary, he’s talking about DirecTV, which is owned by AT&T. Schlichting’s point is that if AT&T’s Time Warner can’t get to a deal with DISH, at least AT&T would know that it might get DISH customers to defect to DirecTV.
“DirecTV has a national service,” testified the DISH executive. “It is more lucrative to take subscribers than to collect programming fees. … In a typical programming negotiation, they will say they want every one of their networks distributed broadly with a rate hike per subscriber. This time [after the merger], I just don’t see them having any motivation to move [off such demands].”
Full Content: Hollywood Reporter
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Fires Head of Copyright Office, Throwing U.S. AI Policy Into Disarray
May 12, 2025 by
CPI
Delta, Korean Air Buy Into WestJet in Major Cross-Border Deal
May 12, 2025 by
CPI
Trump Targets Big Pharma With Tough New Drug Pricing Rules
May 12, 2025 by
CPI
Geradin Partners Expands London Team with New Partner Hire
May 12, 2025 by
CPI
H-E-B Joins Antitrust Battle Against Teva Over MS Drug Monopoly
May 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece